The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Collagen Solutions Plc

23 Apr 2020 12:10



Form 8.3 - Collagen Solutions Plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Rathbone Brothers PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCollagen Solutions Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure22/04/2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:12,354,5512.7845%  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:12,354,5512.7845%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
N/AN/A N/AN/A

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:23/04/2020
Contact name:Angela Hepburn – Compliance Department
Telephone number:0151 236 6666

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
27th Aug 20202:30 pmRNSRecommended Cash Offer for Collagen Solutions plc
19th Aug 20207:42 amRNSForm 8.5 (EPT/NON-RI)
18th Aug 20207:48 amRNSForm 8.5 (EPT/NON-RI)
17th Aug 202012:06 pmRNSRule 2.9 Announcement
13th Aug 20201:35 pmGNWForm 8.3 - Collagen Solutions Plc
13th Aug 20209:28 amRNSForm 8.5 (EPT/NON-RI)
12th Aug 20207:00 amRNSAllotment of shares and total voting rights
10th Aug 20208:04 amRNSForm 8.5 (EPT/NON-RI)
7th Aug 20208:33 amRNSForm 8.5 (EPT/NON-RI)
5th Aug 202010:17 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202010:49 amRNSForm 8.3 - Collagen Solutions PLC
31st Jul 20207:00 amRNSFinal Results
23rd Jul 20208:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 20207:41 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20207:54 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20207:00 amRNSTrading update
16th Jul 202010:51 amRNSForm 8.5 (EPT/NON-RI)
10th Jul 202011:37 amRNSForm 8.3 - Collagen Solutions
10th Jul 202011:15 amRNSAdditional Government Backed Loan Received
10th Jul 20209:30 amRNSForm 8.5 (EPT/NON-RI)
9th Jul 20209:34 amRNSForm 8.3 - Collagen Solutions
7th Jul 20207:00 amRNSCollagen supply agreement with NovaBone Products
6th Jul 20207:00 amRNSRealignment of Bond Repayments
1st Jul 20209:29 amRNSForm 8.5 (EPT/NON-RI)
30th Jun 20208:27 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 202012:07 pmRNSForm 8.5 (EPT/NON-RI)
23rd Jun 202011:04 amRNSForm 8.5 (EPT/NON-RI)
18th Jun 202010:04 amRNSForm 8.5 (EPT/NON-RI)
17th Jun 20209:23 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 202010:06 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 20207:00 amRNSTrading Update and Accounts Filing Extension
8th Jun 20208:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 20209:14 amRNSForm 8.5 (EPT/NON-RI)
2nd Jun 202011:29 amRNSForm 8.5 (EPT/NON-RI)
29th May 20208:30 amRNSForm 8.5 (EPT/NON-RI)
21st May 20208:54 amRNSForm 8.5 (EPT/NON-RI)
20th May 20208:55 amRNSForm 8.5 (EPT/NON-RI)
20th May 20207:00 amRNSGovernment Backed Loan and Grant Funding Received
19th May 20204:40 pmRNSSecond Price Monitoring Extn
19th May 20204:35 pmRNSPrice Monitoring Extension
19th May 20202:06 pmRNSSecond Price Monitoring Extn
19th May 20202:00 pmRNSPrice Monitoring Extension
19th May 202011:05 amRNSSecond Price Monitoring Extn
19th May 202011:00 amRNSPrice Monitoring Extension
19th May 20208:38 amRNSForm 8.5 (EPT/NON-RI)
18th May 20207:00 amRNSStrategic Review and Formal Sale Process Update
11th May 20201:11 pmGNWForm 8.3 - Collagen Solutions Plc
4th May 20208:50 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20204:10 pmRNSForm 8.3 - Collagen Solutions plc
30th Apr 20204:02 pmRNSForm 8.3 - Collagen Solutions plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.